3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
5
Breast Neoplasms
5
Neoplasms
3
Ovarian Neoplasms
2
Neoplasm Metastasis
2
mCRPC
1
Wilms Tumor
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroblastoma
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Acute
1
Hepatoblastoma
1
Hemangiosarcoma
1
Extensive Stage Lung Small Cell Carcinoma
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Adenocarcinoma
1
Interventions
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
olaparib
2
lutetium Lu 177 dotatate
2
gallium Ga 68 dotatate
2
Fluorodeoxyglucose F18
2
6-fluorodopamine
2
tipifarnib
1
fluorodopa F 18
1
fludarabine phosphate
1
belzutifan
1
Temozolomide
1
Nivolumab
1
Ipilimumab
1
Interleukin-13
1
Cyclophosphamide
1
Contrast Media
1
CTLA-4 Antigen
1
Biopsy
1
3-Iodobenzylguanidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pheochromocytoma
×
talazoparib
×
90 days
×
Clear all
No trials found.